Locus coeruleus noradrenergic innervation of the amygdala facilitates alerting-induced constriction of the rat tail artery.
The amygdala, innervated by the noradrenergic locus coeruleus, processes salient environmental events. α2-adrenoceptor-stimulating drugs (clonidine-like agents) suppress the behavioral and physiological components of the response to salient events. Activation of sympathetic outflow to the cutaneous vascular bed is part of the physiological response to salience-mediated activation of the amygdala. We have determined whether acute systemic and intra-amygdala administration of clonidine, and chronic immunotoxin-mediated destruction of the noradrenergic innervation of the amygdala, impairs salience-related vasoconstrictor episodes in the tail artery of conscious freely moving Sprague-Dawley rats. After acute intraperitoneal injection of clonidine (10, 50, and 100 μg/kg), there was a dose-related decrease in the reduction in tail blood flow elicited by alerting stimuli, an effect prevented by prior administration of the α2-adrenergic blocking drug idazoxan (1 mg/kg ip or 75 nmol bilateral intra-amygdala). A dose-related decrease in alerting-induced tail artery vasoconstriction was also observed after bilateral intra-amygdala injection of clonidine (5, 10, and 20 nmol in 200 nl), an effect substantially prevented by prior bilateral intra-amygdala injection of idazoxan. Intra-amygdala injection of idazoxan by itself did not alter tail artery vasoconstriction elicited by alerting stimuli. Intra-amygdala injection of saporin coupled to antibodies to dopamine-β-hydroxylase (immunotoxin) destroyed the noradrenergic innervation of the amygdala and the parent noradrenergic neurons in the locus coeruleus. The reduction in tail blood flow elicited by standardized alerting stimuli was substantially reduced in immunotoxin-treated rats. Thus, inhibiting the release of noradrenaline within the amygdala reduces activation of the sympathetic outflow to the vascular beds elicited by salient events.
Centre for Neuroscience, Department of Human Physiology, Flinders University, Adelaide, South Australia, Australia.
Mazher
M
Mohammed
Centre for Neuroscience, Department of Human Physiology, Flinders University, Adelaide, South Australia, Australia.
Keerthi
K
Kulasekara
Centre for Neuroscience, Department of Human Physiology, Flinders University, Adelaide, South Australia, Australia.
Youichirou
Y
Ootsuka
Centre for Neuroscience, Department of Human Physiology, Flinders University, Adelaide, South Australia, Australia w.w.blesing@flinders.edu.au.
William W
WW
Blessing
D059331:Adrenergic Neurons / Q000502:physiology*; D000679:Amygdala / Q000502:physiology*; D000818:Animals; D001158:Arteries / Q000294:innervation / Q000502:physiology*; D001288:Attention / Q000502:physiology*; D008125:Locus Coeruleus / Q000502:physiology*; D008297:Male; D009434:Neural Pathways / Q000502:physiology; D000069336:Neurovascular Coupling / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D013623:Tail / Q000098:blood supply / Q000294:innervation / Q000502:physiology; D014661:Vasoconstriction / Q000502:physiology*
clonidine; cutaneous blood flow; dopamine-β-hydroxylase; immunotoxin; α2-adrenergic receptor